Antibiotic resistance is a global concern that threatens our ability to prevent and treat bacterial infections in humans and ...
Tulane University researchers have developed a CRISPR-based test that diagnoses Pneumocystis jirovecii pneumonia (PJP)—a life-threatening fungal infection primarily affecting children and ...
Intellia Therapeutics’ stock faces risks from market uncertainty and funding needs. Read why NTLA stock is downgraded to HOLD ...
Mayo Clinic's Precision Mouse Engineering Core in Minnesota produces CRISPR/Cas9-mediated knockout and point mutant mice for researchers.
A team of researchers from the University of Cologne has made an important contribution to understanding the role of the tau ...
A research team at the University of Cologne has made a significant breakthrough in understanding the role of the tau protein ...
Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Intellia's technology platform specializes in Clustered Regularly Interspaced Short ...
Potatoes are being gene-edited to resist fungi in the warm, wet Peruvian Andes. Sorghum is being taught to resist parasitic ...
A vast search of natural diversity has led scientists at MIT’s McGovern Institute and the Broad Institute of MIT and Harvard ...
A vast search of natural diversity has led scientists at MIT's McGovern Institute and the Broad Institute of MIT and Harvard to uncover ancient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback